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The  administration  of antiidiotypic  antibodies  to an  adult  mouse influences 
the expression of the complementary idiotype in a subsequent immune response 
in  a  dose-dependent  fashion.  Nanogram  doses enhance,  and  microgam  doses 
suppress,  the appearance  of the  idiotype-bearing antibodies (for review see  1). 
In  addition,  there  is  evidence  indicating  that  the  heavy  chain  class  of  the 
antiidiotype  antibodies  may  influence  their  regulatory  function  (2-5).  This 
evidence, however, is based on experiments involving the use of antibodies that 
were xenogeneic and/or differed from each other both in specificity and isotype. 
For  a  systematic  investigation  of  the  class  dependency  of  the  regulatory 
properties ofantiidiotope antibodies, we have isolated spontaneous isotype switch 
variants from the hybridomas Ac 146 (6) and A39-40 (7) that secrete monoclonal 
antibodies  specific  for  idiotopes  in  the  variable  (V) 1 region  of the  germline- 
encoded antibody B1-8 (8-10).  B1-8 is an  antibody derived from the  primary 
immune  response  of  C57BL/6  mice  against  the  hapten  (4-hydroxy-3-nitro- 
phenyl)acetyl (NP), and all  idiotopes so far defined on B1-8 monoclonal antiidi- 
otopes are regularly expressed in the humoral anti-NP response of mice bearing 
the Igh b atlotype (6, 7). The family of switch variants isolated from the cell line 
A39-40 consists of antibodies of the IgG 1, IgG2b, and IgG2a classes. The Ac 146- 
variant  family consists of IgG1,  IgG2b,  IgG2a,  and  IgE antibodies  (1 1).  The 
members of a family possess identical idiotope-binding specificity in combination 
with different isotypes and can thus be used for a formal analysis of the effector 
functions  of the  isotypes in  idiotopic regulation.  The  results  presented  in  this 
paper  show  that  the  antiidiotopes  of  a  given  family  have  indistinguishable 
regulatory properties with respect to both enhancement and suppression of the 
idiotypic target. In addition, we find that antibody variable regions differ in their 
sensitivity to regulation by antiidiotope antibodies, depending on their idiotopic 
makeup. 
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spondence to K. R., Institute for Genetics, University  of Cologne, Weyertal 121, D-5000 K61n 41, 
Federal Republic  of Germany. 
Abbreviations used in thispaper:  BSA,  bovine serum albumin; CG, chicken gamma globulin; NIP, 
(4-hydroxy-3-nitro-5-iodo-phenyt)acetyl;  NP, (4-hydroxy-3-nitro-phenyl)acetyl;  PBS, phosphate-buff- 
ered saline pH 7.2; RIA, solid-phase radioimmunoassay; V region, variable region. 
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Materials and  Methods 
Animals.  C57BL/6 and (C57BL]6 ×  CBA)F~ mice were obtained from the breeding 
colony at our institute.  The animals were immunized against ectromelia 4-5 wk before 
the start of an experiment. For the regulatory experiments we used  10-14-wk-old mice. 
Within an experiment the animals were age matched. 
Hybridoma Cell Lines and Monoclonal Antibodies.  The hybridoma cell line B1-8 and its 
subclone B 1-8.64, which secrete an antibody of the IgM class with specificity for N P, have 
been described (8,  11). Affinity-purified antibody B1-8.64 was kindly given to us by Dr. 
T. Takemori. 
The hybridoma cell lines Ac146 (IgGP), Ac38 (IgGP), A39-40 (IgGlb), A25-9 (IgGlb), 
and A6-24 (IgG2a  b) secrete monoclonal antiidiotope antibodies with specificity for distinct 
determinants on the V region of antibody B1-8 (6, 7). We use the same designation for 
an antiidiotope antibody and the target idiotope; i.e., antibody Ac 146 recognizes idiotope 
Ac146,  etc.  From  the cell  lines Ac146.8  and  A39-40.5,  two families of isotype switch 
variants were selected by either fluorescence-activated cell sorting or sequential sublining 
in vitro (11). Within a family, the antibodies express identical idiotope-binding specificities 
and most probably identical  V  regions.  Their K light chains are indistinguishable  from 
each other in analytical isoelectric focusing. Serological and biochemical evidence indicates 
that class switching involved the complete exchange of the constant domains of the heavy 
b  chain. Purified antibody Ls136 (IgG1) specific for ~,I light chains (6) and antibody X63 
(IgG1  a) (12) were gifts of Dr. T. Takemori. 
Put,cation  of Antibodies and Immunosorbents.  Antiidiotope  antibodies  were  purified 
from ascites fluid by precipitation with saturated ammonium sulfate and subsequent ion 
exchange chromatography on DEAE cellulose (Whatman, Ltd., Maidstone, United King- 
dom) as described previously (13). Purified antibodies were examined by analytical sodium 
dodecyl sulfate-polyacrylamide electrophoresis and found to contain <10% material that 
was not  co-migrating with  immunoglobulin (Ig) light or heavy chains.  In addition  the 
antiidiotopes were titrated in solid-phase radioimmunoassay (RIA) (see below) on B1-8- 
coated plates. Antibody concentrations determined in RIA differed by <10%  from the 
concentrations  determined  from  the  absorbance  at  280  nm.  Before  we  injected  the 
antiidiotope antibodies into mice, the specific idiotope-binding activity was again deter- 
mined to assure that the mice received the desired antiidiotope dose. 
Immunosorbents were prepared by coupling purified antibodies to cyanogen bromide- 
activated Sepharose 4B (Pharmacia Fine Chemicals, Freiburg, FRG) (14).  Absorption of 
pooled immune sera was done as described by Takemori et al. (15).  Serum pools were 
diluted with phosphate-buffered saline pH7.2 (PBS) containing 1% bovine serum albumin 
(BSA).  The pools were divided into aliquots and each aliquot was absorbed twice with an 
equal volume of X63-, A39-40-, Ac146-, or A25-9-coupled Sepharose at 4°C overnight. 
Each absorbed serum aliquot was then titrated  in  RIA for residual idiotope-expressing 
antibodies. 
Immunizations.  Antiidiotope antibodies were diluted  in  PBS containing  5  /~g mouse 
serum albumin (gift of T. Takemori) per ml. Groups of five mice were injected intraper- 
itoneally with 0.2 ml antiidiotope dilution. Control mice received only diluent. At various 
times  after  injection  of antiidiotope,  the  mice  were  immunized  with  100  /~g  alum- 
precipitated NP~7-CG (chicken gamma globulin) (16). The animals were bled  12 d  later 
and  the  titers  of (4-hydroxy-3-nitro-5-iodo-phenyl)acetyl (NIP)-binding or  idiotope-ex- 
pressing antibodies determined by RIA. 
Radioimmunoassay.  Titration of ~,l-bearing anti-NP or idiotope-expressing antibodies 
was done as described (15,  17). Plastic plates (Dynatech Deutschland GmbH, Plochingen, 
FRG) were coated with 35 ug of the various antiidiotope antibodies or NIPg-BSA (gift of 
T.  Imanishi-Kari) per ml and incubated with the appropriately diluted  serum samples. 
(Lambda chain-bearing anti-NP antibodies are titrated on BSA coupled to NIP because 
their affinity for NIP is  higher  than  for NP  [16]).  Bound  Xl-bearing antibodies  were 
detected with ~I-labeled antibody Ls136. Antibody isotypes were detected with purified 
~25I-labeled goat antibodies specific for mouse IgG1 and IgG2a, or with monoclonal rat 
antibodies R 14-50 (anti-IgG2b) (11) and R33-24.12 (anti-IgM) (18). 760  MULLER  AND  RAJEWSKY 
Results 
Nanogram Doses of Antiidiotope Antibodies of the IgG1, IgG2b, and IgG2a Classes 
Enhance Idiotope Expression.  It was shown previously (17,  19)  that the antiidi- 
otope antibodies Ac38 and Ac 146 of the IgG 1 isotype enhanced the expression 
of their target idiotope when injected in nanogram doses into adult C57BL/6 
mice several weeks before immunization with the NP hapten. A dose of 10 #g, 
however, had a  suppressive effect. In contrast, an  IgG2a antiidiotope,  A6-24, 
was suppressive at both microgram and nanogram doses, although suppression 
was less efficient in the latter than in the former case (5). This suggested that the 
isotype of an antiidiotope antibody may determine its regulatory function, in line 
with earlier data obtained with guinea pig IgG 1 and IgG2 antiidiotype antibodies 
in mice (2-4).  In subsequent, unpublished experiments, we found some irregu- 
larity  in  the  induction  of idiotope  enhancement in  C57BL/6  mice,  whereas 
enhancement was regularly found in (C57BL/6 ×  CBA)F] animals. In Fig.  1 we 
depict the results of an experiment in  which (C57BL/6  ×  CBA)F~  mice were 
pretreated with  10 ng of three antiidiotope antibodies, Ac146 (IgGlJ), A39-40 
(IgGlb),  and  A6-24  (IgG2ab),  and  immunized  6  wk  later  with  NP-CG.  It  is 
obvious that in all three cases the expression of the target idiotope was enhanced 
5-10-fold as compared with the controls. In each case, not only the expression 
of the  target  idiotope,  but  also  that  of all  other  B1-8  idiotopes  tested  was 
enhanced, whereas the total anti-NP response was unaffected. This accords with 
previous data (17,  19).  It is thus clear that enhancement of idiotope expression 
can be mediated by IgG1 antiidiotopes of thej and b allotype and by an IgG2a  b 
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FIGURE  1.  Enhancement of idiotope expression in (C57BL/6  x  CBA)F1 mice.  Mice were 
injected with diluent (a) or  10 ng of the antiidiotopes Ac146 (b), A39-40 (c), or A6-24 (d) 6 
wk before standard immunization with NP-CG. The animals were bled 12 d after immunization 
and the concentration of ~, 1-bearing antibodies (ordinate) that bound NIP (0) or expressed 
idiotopes Ac146 (0), A39-40 (&), or A6-24 (ml) were determined by RIA. Each experimental 
point represents the geometric mean with standard deviations of antibody titers determined 
in the sera of five mice. IDIOTOPE  REGULATION  BY  ISOTYPE  VARIANTS  76] 
antiidiotope, in a  situation where the allotype of the injected antibodies is also 
expressed on the Ig of the recipients. 
In the experiments illustrated in Fig. 2, we induced enhancement with antiidi- 
otopes differing from each other only in isotype, by using class switch variants 
of the Ac 146 (Igh  i) and A39-40 (Igh  b) antiidiotope-secreting cell lines (11). The 
IgG1,  IgG2b,  and  IgG2a  antibodies  of either  variant  family  caused  similar 
enhancement of the expression of the target idiotope. Enhancement was ~10- 
fold for idiotope Ac146 (Fig. 2.1) and ~5-fold for idiotope A39-40 (Fig. 2.2). 
Microgram Doses of Antiidiotopes of the IgGI,  IgG2b, and IgG2a Class Suppress 
Idiotope Expression.  The  phenomenon of idiotope  suppression  by  microgram 
doses of antiidiotopes was regularly observed in both C57BL/6 and (C57BL/6 
× CBA) F~ mice. In Fig. 3 we depict the expression ofidiotope Ac146 in C57BL/ 
6  mice injected  with  the  IgG1,  IgG2b,  or  IgG2a  antiidiotopes of the  Ac146 
family.  Profound  suppression  of  similar  duration  was  induced  by  all  three 
antiidiotope antibodies, although the curves obtained for each antibody differ 
somewhat from each other.  Similarly, injection of 10 /~g of the IgG1,  IgG2b, 
and IgG2a antibodies of the A39-40 family 4 wk before immunization with NP 
suppressed the expression of idiotope A39-40  to the same extent (Fig. 4).  We 
have also treated C57BL/6 mice with a  1 #g dose of the various IgG antibodies 
of the Ac146 or the A39-40  family. Again the result was similar in all cases in 
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FIGURE 9.  Enhancement of the expression ofidiotopes Ac146 (1) and A39-40 (2) by injection 
of 10 ng IgG 1 (a, e), IgG2b (b,f), or IgG2a (c, g) antibodies of the Ac 146 (I) or A39-40 family 
(2) in (C57BL/6 X CBA)FI mice. Lanes d andfrepresent control responses. For experimental 
details see legend to Fig.  1.  The ordinate gives the concentration of M-bearing antibodies 
that  bind NIP (open symbols) or express idiotope Ac146 or A39-40 (closed symbols). Each 
experimental point represents the geometric mean with standard deviations of antibody titers 
determined in the sera of five mice. In cases where the deviation is not indicated, the symbols 
are bigger than the deviation. 762 
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FIGURE 3.  Suppression of idiotope Ac 146 by the antiidiotope antibodies of the Ac146 family. 
C57BL/6 mice were injected with  10 tag IgG1 (A),  IgG2b (O), or IgG2a (,) antibody of the 
Ac 146 family or with diluent (@) at various times (abscissa) before standard immunization with 
NP-CG. The animals were bled 12 d after immunization and the concentration of ~, !-bearing 
antibodies (ordinate)  that  bound  NIP  (open  symbols) or expressed  idiotope Ac146 (closed 
symbols) were determined by RIA. Each experimental point represents the geometric mean 
with standard deviations of antibody titers determined in the sera of five mice. 
that marginal (two to threefold) suppression of the target idiotopes were obtained 
(data not shown). 
In the above experiments the effects of the antiidiotopes were monitored at 
the  level  of total  ~,l-bearing  serum  antibodies.  To  extend  our  analysis,  we 
investigated the isotype distribution of the antibodies expressing idiotope Ac 146 
in mice pretreated with 10 ug IgG1 or IgG2b antiidiotopes of the Ac146 family, 
4 wk before immunization with NP-CG. In accord with previous results (5,  17), 
the antiidiotopes affected almost exclusively the expression of IgG1  and IgG2b 
antibodies,  while  antibodies  of  the  IgM  class  were  only  marginally  (two  to 
threefold) reduced.  Idiotope  Ac146-expressing antibodies  of the  IgG2a  class 
were below  the  limit  of detection in  control  and  suppressed  mice (data  not 
shown). 
Antiidiotopes of the IgE Class Enhance  and Suppress Idiotope Expression like IgG 
A~ztiidiotopes.  The  isolation  of an  IgE-expressing  class  switch  variant  in  the 
Ac146 family allowed us also to compare antiidiotope antibodies of the IgE and 
IgG class  with respect to their regulatory effects on  idiotope expression.  The 
data in Fig. 5 show that both the IgE and the IgG1 antiidiotopes of the Ac146 
family enhanced expression of idiotope Ac 146 -  10-fold and suppressed it ~ 100- 
fold.  Again,  the regulatory effects were dependent on  the dose and  not  the IDIOTOPE  REGULATION  BY  ISOTYPE  VARIANTS 
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FIGURE 4.  Suppression  of idiotope A39-40  by  the antiidiotope antibodies  of the  A39-40 
family. C57BL/6 mice were injected with 10/~g IgG1 (a), IgG2b (b), or IgG2a (c) antibody of 
the A39-40 family or with diluent (d)  4  wk before immunization with NP-CG. The animals 
were  bled  12  d  after  immunization.  The  ordinate  gives the  concentration  of hi-bearing 
antibodies that bound to NIP (open symbols) or expressed idiotope A39-40 (closed symbols). 
Each experimental plot represents the geometric mean with standard deviations of antibody 
titers determined in the sera of five mice. 
isotype of the injected antiidiotope. Idiotope A25-9 was suppressed to the same 
extent as idiotope Ac146 by injection of antiidiotope Ac146 of the IgG1  class, 
while idiotopes A39-40 and Ac38 were suppressed only about twofold (Fig. 5A). 
The effect of a  suppressive dose of the IgE antiidiotope on the expression of 
nonhomologous idiotopes was not analyzed. In the case of enhancement, how- 
ever, both antiidiotopes co-enhanced the expression of the nonhomolgous idi- 
otopes A25-9, Ac38, and A39-40 (Fig. 5B) 
Idiotopes Appear to Differ in their Sensitivity to Antiidiotopic Regulation.  The extent 
of suppression caused by 10 #g of the antiidiotopes of the Ac146 and the A39- 
40  families differed drastically.  While  the antiidiotopes  of the  Ac146  family 
induced a  100-fold suppression of idiotope Ac146 (Fig.  3), the antiidiotopes of 
the A39-40  family suppressed idiotope A39-40 only 5-10-fold (Figs.  4  and 6). 
However, when the titers of other B1-8 idiotopes in the latter sera were examined 
(Fig. 6), idiotopes Ac 146 and A25-9 were found to be suppressed by more than 
two orders of magnitude, much more than the target idiotope A39-40 itself. In 
fact, the A39-40 antibody suppresses idiotope Ac 146 as efficiently as the homol- 
ogous antiidiotope, antibody Ac 146. 
In a certain way, a similar effect had been seen in the sera of mice pretreated 
with enhancing doses of antiidiotope: antiidiotope A39-40 enhanced the expres- 
sion of idiotope Ac146 as well as that of the homologous idiotope A39-40 (Fig. 
1).  However,  in  contrast  to  the  situation  in  suppressed  mice,  enhancement 
appeared always to affect the expression of all B 1-8 idiotopes tested (Figs.  1 and 
5).  Because of these puzzling results, we investigated the idiotopic makeup of 
anti-NP  antibodies  in  control  and  idiotypically manipulated animals  in  more 
detail. 
Target of Regulation by Antiidiotope Antibodies.  We know from previous experi- 
ments that certain B 1-8 idiotopes can be found expressed together (as on antibody 764  MISLLER  AND  RAJEWSKY 
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FIGURE 5.  Idiotope regulation by antiidiotope antibodies of the IgE class. In one experiment, 
(C57BL/6 x  CBA)F1 mice were injected with 10/Lg IgG1 (a) or IgE (b) antiidiotope antibody 
of the Ac146 family, or with diluent (c) 4 wk before immunization with NP-CG. In a second 
experiment, the animals received  10 ng IgG1  (d) or IgE (e) antiidiotope or diluent (f) 6 wk 
before immunization with NP-CG.  The animals were bled  12 d  after immunization and the 
concentrations  of  Xl-bearing  antibodies  (ordinate)  that  bound  to  NIP  ((5) or  expressed 
idiotopes Ac146 (O),  A25-9 (In), Ac38 (V), or A39-40 (&) were determined by RIA.  Experi- 
mental points represent geometric means with standard deviations of antibody titers deter- 
mined in the sera of five mice. 
B1-8) or independently of each other on the V regions of antibodies (6, 7). We 
extended this analysis and absorbed  sera from control  mice, immunized with 
NP-CG,  on  immunosorbents  coupled  with  the  antiidiotopes  A39-40,  Ac38, 
Ac146, or A25-9. After absorption, the sera were assayed for residual idiotope- 
expressing antibodies.  In Table  I,  we list the percentages of idiotope-bearing 
antibodies that could be absorbed by the various immunosorbents. We had found 
in previous experiments that antibodies bearing idiotope Ac 146 mostly coexpress 
idiotopes Ac38 and A6-24 (7).  The data in Table I confirm the former result 
and show in addition that Ac146-positive antibodies also express idiotope Ac39- 
40. Furthermore, idiotope A25-9 is also mostly (80-90%) molecularly associated 
with idiotope Ac 146 and to >90% included in A39-40-bearing antibodies. Since, 
in  addition,  absorption  with  antibody Ac146  or  A25-9  removes roughly half 
(35-60%) of the Ac38- or A39-40-bearing antibodies, and the latter two idiotopes 
are molecularly associated to  ~50%,  we can define three almost equally sized 
sets of anti-NP antibodies bearing B1-8 idiotopes: antibodies bearing idiotopes 
Ac38,  A39-40,  A6-24,  Ac146,  and, the majority (70-90%),  A25-9  (subset a); 
antibodies bearing idiotope Ac38 but lacking A39-40, Ac 146, and A25-9 (subset 1DIOTOPE  REGULATION BY  ISOTYPE  VARIANTS 
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FIGURE 6.  Expression of idiotopes A39-40, A25-9, Ac146, and Ac38 in mice suppressed 
with antiidiotope A39-40. C57BL/6 mice were injected with 10 ~g antiidiotope antibody A39- 
40 of the IgGl class (unbroken lines) or diluent (broken lines) and immunized with NP-CG at 
various  times (abscissa) after this  treatment. The concentrations  of Xl-bearing  antibodies 
(ordinate) that bound NIP (@) or expressed antiidiotopes A39-40 (@), A25-9 (11), Acl46 (4,), 
or Ac3,8 (#) were determined by RIA 12 d after immunization. Experimental points represent 
geometric means with standard deviations of the antibody titers determined  in the sera of five 
mice. 
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b); and antibodies bearing idiotope A39-40 but lacking Ac38, Ac146, and A25- 
9 (subset c) (20). 
The results of absorption experiments using sera from mice in which idiotope 
expression  had  been  enhanced by  nanogram doses  of antiidiotope show that 
enhancement is essentially restricted to antibodies of subset a (Table I). This is 
demonstrated  by  the ability  of any of the  four antiidiotopes  A39-40,  Ac38, 
Ac146, and A25-9 to absorb from those sera most and in most cases essentially 
all material bearing any of the four corresponding idiotopes, in striking contrast 
to what was found in control anti-NP sera. In one case, a fifth idiotope, A6-24, 
also characteristic for subset a, was included in the analysis and found to behave 
like the four other idiotopes. 
Looking back at the suppression experiments depicted in Figs. 5 and 6 it seems 
that also there the antibodies of subset a are the main target of regulation. This 
is particularly strongly suggested by the data obtained with antibody A39-40, 
which profoundly suppresses idiotopes Ac146 and A25-9, whereas suppression 
of the target idiotope A39-40 is only marginal (Fig. 6). The interpretation that 
microgram doses of  antibody A39-40 selectively suppress the expression of subset 766  MI]LLER  AND  RAJEWSKY 
TABLE  I 
Linkage of ldiotopes in X~-Bearing  Anti-NP Antibody Populations 
Mice injected 
with:* 
Step 2: 
Detecting 
antibodies 
Step 1 : Absorbing antibodies 
A39-40  Ac38  Ac146  A25-9 
Diluent* 
% 
A39-40  >994>99 >99  52  41,39,36,40  40,35 
Ac38  51,50  >99  57,60  52,49,40 
Ac146  >99, >99, >99  >99  >99, >99, >99, >99  91,83,76 
A25-9  92,96  71  80,90,83  >99, >99, >99 
A6-24  ND  ND  84  74 
10 ng Ac146'  A39-40  >99  99  99  99 
Ac38  97  >99  95  94 
Ac146  >99  >99  >99  >99 
A25-9  >99  >99  99  >99 
10 ng A39-40'  A39-40  ND  ND  95  97 
Ac38  ND  ND  80  80 
Ac146  ND  ND  >99  99 
A25-9  ND  ND  99  >99 
A6-24  ND  ND  >99  >99 
* Pooled sera of five to six mice were analyzed. 
* Given 6 wk before immunization with NP-CG. 
Percent absorption, corrected for nonspecific absorption on X63-coupled Sepharose. ND, not done. 
a anti-NP antibodies was verified by the absorption experiments depicted in Fig. 
7. 
In mice injected with the antiidiotope 4  wk before immunization, antibodies 
expressing idiotopes Ac 146 and A25-9 (subset a) are hardly detectable. However, 
antibodies expressing idiotope A39-40 are again only slightly reduced, in accord 
with the data in  Fig. 6.  One can calculate from the data in Fig. 6 and Table I 
that antibodies expressing idiotope A39-40  but lacking the Ac146 and A25-9 
determinants (subset  c)  are  only  reduced  3.5-fold  at  this  point  in  time  and 
represent >90% of the total A39-40-bearing population, in contrast to the 60% 
found  in  controls  (Table  I  and  Fig.  7).  In  the  sera  of mice  injected  with 
antiidiotope A39-40  6 wk before immunization with NP-CG, the titers of anti- 
bodies of subset c are only about twofold lower than in the controls. Antibodies 
of subset a  have partially recovered from suppression, but recovery from sup- 
pression is  more rapid  for those subset a  antibodies that  lack idiotope A25-9. 
The preferential suppression of A25-9-bearing antibodies of subset a, suggested 
by the data in Fig. 6, is strikingly born out by the absorption experiments (Fig. 
7).  While in  control sera,  80-90%  of Ac146-bearing antibodies coexpress idi- 
otope  A25-9,  only ~20%  of Ac146-positive antibodies  do  so  in  anti-NP  sera 
obtained 6 wk after suppression the A39-40 idiotope. Again, however, the A25- 
9 idiotope is largely confined to Ac 146-positive antibodies (Fig. 7). These results 
demonstrate that even within the subset a antibodies, idiotypic phenotypes can 
be ordered on the basis of their sensitivity to idiotypic regulation: the more the 
antibodies idiotypically resemble antibody B1-8, the better they are suppressed. IDIOTOPE  REGULATION  BY  ISOTYPE  VARIANTS  767 
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FIGURE  7.  Linkage of idiotopes Ac146, A25-9, and A39-40 on serum antibodies of C57BL/ 
6 mice suppressed with 10 t~g of antiidiotope A39-40.  Pooled sera of mice injected with IgG 1 
or  IgG2b  antiidiotopes  of the  A39-40  family  4  wk (a-c)  or  6-8  wk  (d-f)  before  standard 
immunization  with NP-CG were absorbed twice on Sepharose  coupled to X63 protein (a, d) 
or the antiidiotope antibodies A25-9 (b, e) and Ac 146 (c, f). The concentrations of h 1-bearing 
antibodies (ordinate) expressing idiotopes Ac146 (11), A25-9 (B), or A39-40  (1"7) were deter- 
mined in the absorbed sera. Column g  shows the concentrations of these idiotopes in control 
sera (from NP-CG-immunized mice preinjected with diluent) absorbed with X63 protein. For 
an analysis of idiotope linkage in such sera see Table I. 
Discussion 
Regulatory Properties of Antiidiotopes of Different Isotypes.  The isolation of families 
of class switch  variants from  hybridoma  cell  lines secreting  monoclonal antiidi- 
otope antibodies  (11)  enabled  us to compare  the regulatory  properties  of anti- 
idiotope antibodies that differ from each other only in heavy chain isotype,  but 
share all other properties,  including binding specificity. The cell lines Ac 146 and 
A39-40,  from which we selected  isotype variants, secrete  antibodies specific for 
idiotopes on the germline-encoded  V region of antibody B 1-8. Both antiidiotopes 
regulate the expression of their target idiotopes in a subsequent immune response 
against  NP.  The  antiidiotope  antibodies  of the  IgG1,  IgG2b,  IgG2a,  and  IgE 
class  of the  Ac146  or  A39-40  families  enhance  or  suppress  the  expression  of 
their target idiotopes, depending on the dose but not the isotype of the injected 
antiidiotope.  We  thus  conclude  that  for  the  function  of  an  antiidiotope  in 768  MOLLER AND RAJEWSKY 
idiotypic regulation of the humoral response, it is irrelevant whether it expresses 
the IgG1, IgG2b, IgG2a, or IgE class. 
In  the course of the present experiments, we found an  irregularity of the 
enhancing phenomenon in C57BL/6 but not in (C57BL/6 X CBA)F~ mice. The 
expression of idiotope-bearing antibodies in  idiotypically manipulated animals 
may depend on an interaction of suppressive and enhancing forces. In C57BL/ 
6  mice injected with  1 ~g antiidiotope antibody Ac38,  the expression  of the 
target idiotope is neither enhanced nor suppressed (17,  19).  An analysis of the 
in vitro immune response to NP-Ficoll of spleen cells from these mice revealed 
that the removal of T  cells bearing the Lyt-2 marker resulted in an enhanced 
expression of the target idiotope (G.  Kelsoe, T.  Takemori, and K.  Rajewsky, 
unpublished  data).  The  balance  between  enhancement and  suppression  may 
often be shifted towards suppression in the C57BL/6  mice in our colony. The 
variability of the enhancing phenomenon in C57BL/6 mice allows a reinterpre- 
tation  of previous  results  pointing  to  isotype-dependent regulation.  In  these 
experiments,  antiidiotope  A6-24  (IgG2ab),  in  contrast  to  antiidiotope  Ac38 
(IcGlJ), did not enhance, but slightly suppressed the target idiotope at nanogram 
doses in the C57BL/6 strain (5). In unpublished experiments we have reproduced 
this result. However, antiidiotope A6-24 enhances its target idiotope in (C57BL/ 
6 x  CBA)F~ mice as well as any other antiidiotope so far tested (Fig.  1). 
Our  results  accord  with  data  from  the  T15  system  (21),  indicating  that 
antiidiotypic  antibodies  of the  IgG3,  IgG1,  IgG2b,  and  IgG2a  classes  of a 
conventional antiidiotypic serum suppressed an immune response against phos- 
phorylcholine to the same extent in vitro. However, distinct effector functions 
in idiotypic regulation have been assigned to the isotypes of antiidiotypic anti- 
bodies in the A5A system. Guinea pig antiidiotypic antibodies of the IgG1 class 
enhanced or suppressed A5A idiotype expression in A/J mice in a dose-dependent 
fashion, while IgG2 antibodies of the same origin were suppressive at all doses 
(2-4). The discrepancy between these and the present results could have several 
reasons.  First,  the different isotypes of guinea pig IgG antibodies may indeed 
induce different regulatory mechanisms in the mouse. As long as murine anti- 
bodies  of different  isotypes  do  not  have  the  same  effects,  the  physiological 
significance of such a phenomenon would remain in doubt, in particular since 
IgG1 and IgG2 antibodies are distinguished from each other in a similar way in 
both mice and guinea pigs in  terms of their effector functions in complement 
activation and  Fc receptor binding (22).  Alternatively, as the guinea pig anti- 
A5A sera contained presumably a variety of antiidiotope specificities, antisera of 
different idiotope-binding specificity and affinity might have been generated by 
separating the two isotypes.  Although we are unable to spell  out the possible 
regulatory consequences of such a situation in terms of a mechanism, the question 
remains whether different distributions  of idiotype-binding specificities might 
have been  responsible  for the distinct  regulatory functions of the guinea pig 
IgG1 and IgG2 antibodies, rather than the two isotypes themselves. 
However, a few words about the limitations of our analysis should be added. 
Thus,  we have not investigated the cellular basis of idiotype suppression and 
enhancement for the various antiidiotope isotypes, except that of suppression by 
IgG1  antibodies (1,  23;  T.  Takemori and K.  Rajewsky, submitted for publica- IDIOTOPE  REGULATION  BY  ISOTYPE  VARIANTS  769 
tion).  Although  suppressor  T  cells  have  been  identified  in  the  latter  case,  in 
contrast to the results with guinea pig IgG1  antibodies, it remains a  possibility 
that  the  regulatory  mechanisms induced by antiidiotopes of different  isotype 
differ from each  other  in detail.  Furthermore,  we have  not yet excluded the 
possibility that antiidiotope antibodies of isotypes other than IgG 1, IgG2b, IgG2a, 
and  IgE  may have  regulatory  properties other  than antibodies of the former 
isotypes. Antiidiotopes of the IgM, IgD, IgA, and IgG3 class are not available in 
our system. 
The Target of Idiotypic Regulation.  As an unexpected result, we found that both 
enhancement  and  suppression  by  antiidiotope  antibodies  was  predominantly 
expressed in a certain subset (subset a) of anti-NP antibodies bearing the target 
idiotope, namely antibodies coexpressing with the target idiotope other idiotopes 
of antibody B1-8 against which the antiidiotope antibodies had originally been 
raised.  The present data  show that  this subset  is  selectively regulated  by  two 
different antiidiotopes (Ac146 and A39-40) and suggest that this is also true for 
a third one, antibody A6-24 (Fig.  1). In a  separate study (T. Takemori and K. 
Rajewsky,  submitted for  publication;  see also  reference  1.)  it  was  shown that 
neonatal suppression induced by yet another antiidiotope, antibody Ac38, was 
again predominantly expressed  in  subset a  antibodies.  The  fact that idiotypic 
regulation of the expression of a  set of antibody V  regions can be induced by 
antiidiotope antibodies recognizing any of the idiotopes shared by those V regions 
supports the view (24) that the V  regions themselves are the primary target of 
the injected antiidiotope. The interaction of the antiidiotope antibody with the 
target V regions would initiate the chain of events leading in the end to idiotypic 
suppression or enhancement (20). A similar conclusion was reached by Cerny et 
al.  (25)  in  their  study  of  idiotypic  suppression  in  the  T15  system.  In  our 
experimental system, as in many others (see reference  1 for review), T  cells are 
involved in the regulatory process at least in the case of suppression (23), and 
recent studies indicate that these T  cells indeed specifically regulate the expres- 
sion  of subset  a  antibodies  (1;  T.  Takemori,  and  K.  Rajewsky,  submitted for 
publication). 
Ongoing work aims to elucidate the peculiar specificity of idiotypic regulation 
observed  in  our  experiments.  Why are  subset  a  antibodies  preferentially  en- 
hanced  or  suppressed  by  antiidiotypic  manipulation?  One  can  imagine  that 
antibody-mediated idiotypic regulation exhibits a high degree of selectivity, based 
on the affinity of the antiidiotope for its idiotypic target. Thus, antibodies raised 
against B1-8 idiotopes may best fit to V  regions whose overall shape resembles 
closely that of antibody B1-8, and this may define anti-NP antibodies of subset 
a. This simple view is not supported by experimental evidence demonstrating a 
similar affinity of antibody Ac38 for its original target (antibody B1-8) and for 
Ac38-binding antibodies in anti-NP sera, irrespective of whether they coexpress 
(subset  a)  or  lack  (subset  b)  idiotope Ac146  (T.  Takemori  and  K.  Rajewsky, 
submitted for publication). One might therefore consider an alternative model, 
namely that  the  regulatory  T  cells like to see B1-8-1ike  molecules in  anti-NP 
responses,  possibly because  of peculiarities  of the  T  cell  receptor  repertoire. 
These considerations lead  us into the problem of the control of the antibody 
repertoire by T  cells.  One might wonder whether such a  control has played a 770  MISLLER AND RAJEWSKY 
role  in  the generation  of the  plasma  cell  that  was  immortalized in  the  B1-8 
hybridoma. 
Summary 
Previous work has shown that the injection of antiidiotope antibodies specific 
for idiotopes of the germline-encoded anti-(4-hydroxy-3-nitro-phenyl)  acetyl (NP) 
antibody  B1-8  enhanced  or  suppressed  the  expression  of B1-8  idiotopes  in 
subsequent humoral anti-NP responses, depending on the dose and perhaps also 
the isotype of the injected antibody. To formally answer the question of whether 
the isotype of an antiidiotope determines its  effector function in  this  type of 
idiotypic control, we have performed regulatory experiments with isotype switch 
variants  selected from  two  hybridomas secreting anti-B1-8  idiotopes  of CBA 
(Igh  j) and C57BL/6  (Igh  b) origin. The antibodies of each variant family differ 
from each other only in the constant region of the heavy chain. The results show 
that,  irrespective  of whether an  antiidiotope  antibody  belongs  to  the  IgG1, 
IgG2b, IgG2a, or IgE class, a  10-ng dose enhances idiotope expression whereas 
a dose of 10 ~g exerts a suppressive effect. 
It emerges from the present and parallel data that the expression of antibody 
V regions resembling idiotypically that of antibody B1-8 can be enhanced and 
suppressed by any of four antiidiotope antibodies that recognize distinct idiotopes 
on those V regions. This suggests that the initial step in the regulatory process 
induced by an  antiidiotope  is  its binding  to  antibody V  regions carrying the 
target  idiotope.  The  antiidiotopes  preferentially  regulate  the  expression  of 
antibodies that coexpress with the target idiotope other B1-8 idiotopes, despite 
the fact that some B 1-8 idiotopes are also expressed independently of each other 
in  anti-NP  responses  of idiotypically unmanipulated  mice.  This  finding  may 
reflect high affinity binding of the antiidiotopes to the target against which they 
were originally raised (i.e., antibody B1-8) or, more likely, a preferential recog- 
nition of B 1-8-like V regions by regulatory T  cells. 
We are grateful to Dr. T. Takemori and Dr. A. Radbruch for gifts of reagents and to 
many colleagues in the laboratory for advice and discussion. 
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